Pharmafile Logo
Pharmafocus logo
Advanced Search
LaMattina image

John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?

February 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency

You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …

Feature

Pharma losing in ‘valley of death’

February 21, 2013
Research and Development, Sales and Marketing Bath, Evotec, pharma

An academic from Bath University has warned that much of pharma’s most promising research is being lost before it can …

News
hakan_bjorklund

Lundbeck elects new chairman

February 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck

Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down. Pettersson, a …

Appointment

SHL to invest 40 Million USD in 2013 to significantly expand production facilities

February 21, 2013
Manufacturing and Production auto injectors, autoinjector, drug delivery, pen injectors

SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices …

News
Press release
johnny-marshall

NHS Confederation appoints two directors

February 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, confederation

The NHS Confederation has announced the appointment of two new directors to the organisation. Dr Johnny Marshall (pictured) and Matt …

Appointment
GSK image

FDA accepts GSK’s Anoro

February 20, 2013
Research and Development, Sales and Marketing FDA, GSK, Theravance, anoro

The FDA has accepted a New Drug Application for GlaxoSmithKline and biopharma firm Theravance’s investigational COPD drug UMEC/VI. A decision …

News

Phytopharm suffers Parkinson’s loss

February 20, 2013
Research and Development, Sales and Marketing Parkinson's, Phytopharm, cogane

Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …

News

Strategic North launches thought leaders book

February 20, 2013
Medical Communications Strategic North, health policy

A healthcare consultancy has launched a book collecting thoughts and insights from experts in health and beyond.Strategic North, a strategic …

News
carolyn_dodd_bw

Director-level role hire at Insight Research Group

February 20, 2013
Medical Communications, Research and Development, Sales and Marketing Insight Research Group, carolyn dodd

Carolyn Dodd has taken up a director-level position at healthcare consultancy firm Insight Research Group. Dodd previously spent 12 years …

Appointment

VBP negotiations ‘opened up’

February 19, 2013
Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP

Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …

News

Vasella forgoes golden handshake after furore

February 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella

Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …

News
GSK image

GSK plans greater use of biocatalysis, continuous processing

February 19, 2013
Manufacturing and Production GSK, Witty, biocatalysis

GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …

News
michel_dubery

inVentiv Health names new European head

February 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health

Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …

Appointment
EMA image

EU orphan designations rise

February 19, 2013
Research and Development, Sales and Marketing COMP, EMA, Orphan, hta

The number of orphan drug designations in the EU is set to rise to record levels this year, according to …

News

New director at Havas PR

February 19, 2013
Medical Communications Havas, Louise Stone, PR

Havas PR has brought in healthcare consultant Louise Stone to strengthen its health and wellness business. Louise takes on the role …

News

Genzyme’s Waterford plant gets new investment round

February 19, 2013
Manufacturing and Production Genzyme, Sanofi, Waterford

Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …

News
Gilead image

Gilead recalls Vistide on particle contamination

February 19, 2013
Manufacturing and Production Gilead, Vistide

Gilead Sciences has issued a voluntary recall of one lot of its antiviral treatment Vistide after finding particulate matter in …

News
Takeda HQ image

CMO plant shut down after Takeda product recall

February 19, 2013
Manufacturing and Production CMP, OPG, Takeda

Japan’s regulatory authorities flexed their enforcement muscles last week when it ordered a temporary shutdown of the contract manufacturer for …

News

ViiV HIV drug boost

February 18, 2013
Sales and Marketing Dolutegravir, GSK, HIV, ViiV

ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …

News
merck_and_co

Merck makes $688m payout

February 18, 2013
Sales and Marketing ENHANCE, Inegy, Merck, Vytorin, investors

Merck has paid out $688 million to end two class-action lawsuits which sprang up after the revelation of disappointing trial …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026